Key facts
- In April 2025, 975 measles cases were reported by 18 countries. Eleven countries reported zero cases.
- Overall, four measles-related deaths have been reported in the EU/EEA in 2025, all of them in Romania.
- Overall, case numbers decreased compared with the previous month; however, this is subject to change in the event of a future retrospective update.
- Outbreaks associated with imported measles cases have been reported in Belgium and Germany.
Overview
In April 2025, 29 countries reported measles data, with 975 cases reported by 18 countries. There were 11 countries that reported zero cases.
Overall, case numbers decreased compared with the previous month; however, this is subject to change in the event of a future retrospective update. The highest case counts were reported by Romania (402), France (186), Netherlands (111), Belgium (100) and Spain (52).
Between 1 May 2024 and 30 April 2025, 30 EU/EEA Member States reported a total of 22 481 cases of measles, 15 633 (69.5%) of which were laboratory confirmed. Of the total reported cases with known age, 9 852 (43.8%) were in children under five years old and 6 371 (28.3%) cases were in individuals 15 years old or above. The highest notification rates were observed among infants under one year old (768.3 cases per million) and children one to four years old (424.4 cases per million).
Of 20 669 cases (100.0% of all cases) with a known age and vaccination status, 17 678 (85.5%) were unvaccinated, 1 851 (9.0%) were vaccinated with one dose of a measles-containing vaccine, 1 067 (5.2%) were vaccinated with two or more doses, and 43 (0.2%) were vaccinated with an unknown number of doses.
Fourteen deaths (case fatality rate (CFR): 0.1) attributable to measles were reported to ECDC during the 12-month period by Romania (12) and France (2). Detailed data are available in ECDC's Surveillance Atlas of Infectious Diseases.
Complementary epidemic intelligence surveillance has been conducted, with data collection between 11 and 13 June 2025. Ongoing outbreaks or considerable increases were reported in Belgium (Flanders region), Germany (Bavaria region), and Romania. Sporadic cases have been reported in Austria, Czechia, Denmark, Estonia, Italy, Lithuania, the Netherlands, Poland, Slovakia, and Spain.
Disclaimer: The monthly measles report published in the CDTR provides the most recent data on cases and outbreaks based on information made publicly available by the national public health authorities or the media. Sometimes this information is made available retrospectively. This report is a supplement to ECDC’s monthly measles and rubella monitoring report, based on data routinely submitted by 30 EU/EEA countries to TESSy and EpiPulse. Data presented in the two monthly reports may differ.
Epidemiological summary for EU/EEA countries with relevant epidemic intelligence updates:
Austria reported 116 measles cases in 2025 and as of 11 June 2025, an increase of 21 cases since 7 May 2025. In the recent four weeks, one to five cases have been reported across Austria with recent cases being reported from Vienna, Upper Austria and Steiermark. Relevant information was available for 106 cases, of which 28 were hospitalised (26.4%), including one patient being treated in an intensive care unit. No outbreaks have been reported.
Belgium: The outbreak continues in Flanders, with 82 cases reported only in May, of which 48 cases were in Antwerp and 31 in Limburg, as of a report on 2 June by the Flemish public health authority. The outbreak was notified in April 2025, mainly affecting Antwerp. Most of the cases are children zero to nine years old. Overall in 2025, 178 cases of measles have been reported in the Flanders region, with 108 cases reported in Antwerp and 33 in Limburg. Of the reported cases, 43% were hospitalised. In Limburg, measles cases have mostly occurred in large families.
Czechia reported 16 cases as of 2 June 2025.
Denmark reported four measles cases in 2025, as of 13 June (an increase of three since January).
Estonia has reported five cases from January to May 2025.
France: An increase in cases and number of outbreaks is observed in 2025 since 2023. According to the national public health authorities, the number of cases in the first quarter of 2025 (427 cases, including one death as of 13 April 2025) has reached the overall annual number of cases reported in 2024 (483 cases; 0.58 cases per 100 000 population). The increase is caused by transmission occurring due to imported cases as well as locally acquired infections. For more details, please read reports of the French authorities.
Germany reported 188 confirmed and probable measles cases in 2025 and as of 13 June 2025, an increase of 40 cases since 12 May 2025.
An outbreak related to an international festival in Jandelsbrunn/Zielberghas, Bavaria, Germany that took place in the beginning of May 2025 was reported on 4 June 2025, comprising at least 18 cases from Germany, Czechia, Italy, Poland and the United Kingdom. Please see a separate item on this with a respective assessment in this issue of the CDTR.
Italy reports a continuous increase of cases in 2025. As of data on 31 May, in 2025 there have been 334 cases reported, of which 65 cases were reported in May 2025. Nineteen regions reported measles, with the majority of cases observed in Sicily, Lombardy, Lazio and Emilia-Romagna. Almost half of the cases (48.8%) are 15 years old or above (median age: 32 years old); however, the highest incidence is seen in children under five years old. The vast majority of cases are unvaccinated (275 cases; 87.9% of those with known vaccination status – 313 cases).
Lithuania reported five cases in 2025 as of 12 June 2025, an increase of two cases since the end of March 2025.
The Netherlands reported 437 cases of measles as of 28 May 2025, indicating a slow decrease. The reports are mainly comprising individual cases and several small clusters with transmission occurring within families and daycare centres. There is no indication of a national outbreak. In 2025, 50 cases were reported to have contracted measles abroad. Most of these contracted infection in Morocco (33), but other cases had travel history to Greece, Romania, Viet Nam, Türkiye, Belgium, Uganda, Iran, and Bosnia and Herzegovina. In addition, the national public health authority (RIVM) reported on 12 June 2025 one death with measles in an adult with underlying conditions.
Poland reported 51 measles cases in 2025 and as of 31 May, an increase of five cases since 30 April 2025.
Romania reported 7 416 measles cases and eight deaths in 2025 and as of 31 May, an increase of 1 015 cases since April 2025. No new deaths were reported in this reporting period. A decreasing trend is observed in 2025, with three to four times less cases reported per month compared with the same period in 2024.
Slovakia reported two unrelated cases in an adult and a child on 27 March 2025.
Spain reported 303 cases as of 8 June 2025 (229 case reported as of 11 May 2025), of which 93 were imported and 89 were related to imported cases.
Epidemiological summary for select countries outside of the EU/EEA with relevant epidemic intelligence updates:
According to the WHO Pan American Health Organization (WHO PAHO) report on 10 June, 4 592 confirmed cases were reported by nine countries, of which the majority of cases are reported by Mexico (1 888), Canada (1 494) and the United States (US) (1 166).
According to a WHO Western Pacific Region (WHO WPRO) report for January to April 2025, there were 3 353 confirmed measles reported in the region in 12 countries. Most of the cases have been reported in Cambodia (1 060) and China (1 002), followed by Mongolia (377), the Philippines (232) and Viet Nam (144).
Apart from ongoing outbreaks reported previously, no new large outbreaks have been detected in this reporting period through ECDC epidemic intelligence activities. For more information on provisional number of cases outside the EU/EEA region, please visit the WHO website.
The numbers provided to WHO for EU/EEA countries are from TESSy data, which are updated monthly and available on the ECDC Surveillance Atlas of Infectious Diseases. Due to differences in reporting times, the numbers may not correspond to the data from epidemic intelligence screening.
ECDC assessment
The overall number of measles cases in the EU/EEA increased steadily between June 2023 and March 2024, before decreasing between April 2024 and March 2025.
Measles cases may continue to increase in the EU/EEA in the coming months, in line with measles' observed seasonality. This is due to reported suboptimal vaccination coverage for measles-containing vaccines (MCV) in a number of EU/EEA countries, as well as a high probability of importation from areas experiencing high circulation. The majority of recently reported cases have acquired the disease within the reported country through community/local transmission; however, cases related to international travel have been reported.
Actions
ECDC is monitoring the measles situation through its epidemic intelligence activities. Data collected via epidemic intelligence supplement the monthly outputs that present measles surveillance data from TESSy, which are routinely submitted by 30 EU/EEA countries.
As the number of cases is expected to rise in the near future, ECDC urges EU/EEA public health authorities to focus on the following areas:
- Close immunity gaps, achieve and maintain high vaccination coverage for MCV (>95% with the second dose). It is vital to ensure first and second dose vaccinations are administered on time as per national schedules among infants and children. It is also important to identify and vaccinate eligible individuals (for example, non-immune adolescents and adults) in immunisation catch-up programmes (as recommended by local and national authorities).
- Strive towards high-quality surveillance and adequate public health capacity, especially for early detection, diagnosis, response and control of outbreaks.
- Increase the clinical awareness of health professionals, including reminding them of the importance of checking individuals' vaccination status ahead of travel.
- Healthcare professionals should be fully vaccinated.
- Promote vaccine acceptance and uptake by employing specific risk communication strategies and identifying drivers of suboptimal MMR vaccine acceptance and uptake to ensure that tailored interventions are implemented in response.
- Address barriers and engage with under-served populations. Systemic barriers that impact vaccine uptake in under-served, isolated and difficult-to-reach populations need to be monitored and addressed with targeted strategies in order to reduce inequalities in vaccine uptake.
ECDC's latest advice on measles is available in the Threat Assessment Brief 'Measles on the rise in the EU/EEA: Considerations for a public health response', published in February 2024 and the conclusions remain valid. Additional information on the risk classification and ECDC recommendations can be found in this report.